Introduction
============

Glaucoma is a common eye disease, and approximately 50% of glaucoma cases are primary open-angle glaucoma (POAG) \[[@r1]-[@r3]\]. In clinical practices, patients with POAG can experience glaucomatous optic neuropathy and visual field defects in the corresponding area for no obvious reasons. POAG can result in blindness if left untreated. The main clinical manifestations of POAG are optic neuropathy, including size increases of the optic disc, and the irregular loss of optic disc tissues. It is considered the second-most frequent cause of irreversible blindness globally, and it affects primarily the older population, estimated to affect about 80 million people worldwide by the year 2020 \[[@r1]\]. However, the etiology of glaucoma remains unclear. Epidemiological studies suggested that POAG is a complex multifactorial disease resulting from the interaction between genetic background and traditional risk factors, including diabetes, myopia, cigarette smoking, and a positive family history \[[@r4]-[@r6]\]. Recently, many genes were found to be associated with POAG, including the lysyl oxidase-like 1 (*LOXL1*; Gene ID: 4016) gene, which is a member of the lysyl oxidase family, which catalyzes the oxidative deamination of lysine residues of tropoelastin and is thought to be essential for elastogenesis \[[@r7],[@r8]\]. Dysregulated expressions of *LOXL1* and elastic proteins were associated with pronounced structural alterations to the elastic fiber network in the laminar beams of pseudoexfoliation syndrome eyes \[[@r7]\]. Theoretically, there was a relationship between *LOXL1* gene polymorphisms and POAG. Recent studies suggested that there was an association between *LOXL1* gene polymorphisms, such as [rs2165241](http://www.ncbi.nlm.nih.gov/snp/?term=rs2165241), [rs1048661](http://www.ncbi.nlm.nih.gov/snp/?term=rs1048661), and [rs3825942](http://www.ncbi.nlm.nih.gov/snp/?term=rs3825942), and POAG susceptibility \[[@r9]-[@r14]\]. As well, a previous study \[[@r15]\] suggested that these three single nucleotide polymorphisms (SNPs) demonstrated a strong linkage disequilibrium ([rs1048661](http://www.ncbi.nlm.nih.gov/snp/?term=rs1048661)-[rs3825942](http://www.ncbi.nlm.nih.gov/snp/?term=rs3825942): D' = 1; [rs1048661](http://www.ncbi.nlm.nih.gov/snp/?term=rs1048661)- [rs2165241](http://www.ncbi.nlm.nih.gov/snp/?term=rs2165241): D' = 0.8; [rs3825942](http://www.ncbi.nlm.nih.gov/snp/?term=rs3825942)- [rs2165241](http://www.ncbi.nlm.nih.gov/snp/?term=rs2165241): D' = 0.8). Furthermore, [rs1048661](http://www.ncbi.nlm.nih.gov/snp/?term=rs1048661) and [rs3825942](http://www.ncbi.nlm.nih.gov/snp/?term=rs3825942) have been identified to be associated with POAG, and this association was later independently replicated in other patient cohorts \[[@r16],[@r17]\]. Although an association between [rs2165241](http://www.ncbi.nlm.nih.gov/snp/?term=rs2165241) and increased POAG risk was found in the Icelandic population, the association was not found in other populations \[[@r16],[@r18]\]. Liu et al. \[[@r19]\] reported that subjects carrying the C allele had a significantly lower risk of suffering from POAG. However, the findings by Fuse et al. \[[@r20]\] were contrary. Therefore, to clarify the relationship between *LOXL1* gene polymorphisms and POAG further, we have systemically examined the association of these SNPs with POAG in the present study.

Methods
=======

Literature inclusion criteria and exclusion criteria
----------------------------------------------------

All the included studies must meet the following criteria: (1) Type of study: case-control or cohort studies; (2) content of study: *LOXL1* gene polymorphisms and POAG susceptibility; (3) data: studies providing genotype and allele frequencies. We excluded studies that 1) provided incomplete data and that cannot be used to extract genotype and allele frequencies; 2) presented unreliable genotyping methods; 3) published repeated data from the same study.

Identification and eligibility of relevant studies
--------------------------------------------------

To identify all articles that examined the association of *LOXL1* polymorphisms with POAG, we conducted a literature search of the PubMed, EMBASE, CNKI, Wanfang, and VIP databases until February 2014 using the following MeSH terms and keywords: "*LOXL1*" of "lysyl oxidase-like 1"; and "polymorphism" or "SNP" or "mutation"; and "primary open angle glaucoma" or "POAG." Additional studies were identified by a manual search of references from original studies or review articles on this topic.

Statistical methods
-------------------

Revman 5.2 statistical software was used to perform the meta-analysis. The odds ratios (OR) of the genetic *LOXL1* polymorphisms were combined and calculated, the 95% CIs were calculated, and the forest plots of the OR value ​​distributions were drawn. Statistical heterogeneity was performed using an I^2^ test analysis. If I^2^ \<50%, all the included studies had no significant statistical heterogeneity regarding OR quantity. The fixed effects model was adopted, and the random effects model analysis was used if the status was conversed.

Results
=======

Literature inclusion
--------------------

As shown in [Figure 1](#f1){ref-type="fig"}, the relevant databases were reviewed and 132 literatures were found to meet the inclusion criteria for the meta-analysis. Of the 132, 119 literatures were excluded due to duplicated publications, non-clinical-based research, or non-availabilities of full texts. In total, 13 literatures \[[@r12],[@r19]-[@r30],\] were included, all of which were case-control studies totaling 5,293 subjects. The characteristics of the included studies were shown in [Table 1](#t1){ref-type="table"}.
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###### The characteristics of included studies.

  Authors               Publication year   Country         Ages (years)   rs1048661 (n)   H-W for   rs3825942 (n)   H-W for   rs2165241 (n)   H-W for                       
  --------------------- ------------------ --------------- -------------- --------------- --------- --------------- --------- --------------- --------- ------- ----- ----- -------
  Lemmela et al.        2009               Finland         NA             NA              71        404             0.113     71              404       0.664   71    404   0.221
  Fan et al.            2008               United States   75             72              331       88              0.227     331             88        0.112   331   88    0.327
  Liu et al.            2008               United States   55.4±13.8      \>55            \-        \-              0.365     642             462       0.435   642   462   0.164
  Chakrabarti et al.    2008               India           NA             NA              112       105             0.443     112             105       0.665   112   105   0.143
  Fuse et al.           2008               Japan           NA             68.0±7.0        62        138             0.556     62              138       0.221   62    138   0.779
  Tanito et al.         2008               Japan           75.4±5.3       77.2±5.0        40        157             0.212     40              157       0.476   40    157   0.088
  Cong et al.           2008               China           39.1±16.5      69.4±6.0        462       447             0.098     462             447       0.127   462   447   0.123
  Thorleifsson et al.   2007               Europe          NA             NA              200       198             0.119     200             198       0.659   200   198   0.943
  Abu-Amero et al.      2012               Saudi Arabia    63.7±14.7      69.3±12.4       96        101             0.876     96              101       0.212   96    101   0.558
  Zanon-Moreno et al.   2014               Spain           NA             NA              \-        \-              \-        \-              \-        \-      232   241   0.332
  Mabuchi et al.        2008               Japan           \>40           \>40            213       191             0.211     213             191       0.665   \-    \-    \-
  Williams et al.       2010               South Africa    NA             NA              50        50              0.332     50              50        0.443   \-    \-    \-
  Kasım et al.          2013               Turkish         67.7±9.3       66±5.7          100       100             0.126     100             100       0.119   \-    \-    \-

Meta-analysis
-------------

All the publications including these three SNPs showed no significant heterogeneity ([rs2165241](http://www.ncbi.nlm.nih.gov/snp/?term=rs2165241): I^2^ = 43%, p = 0.07; [rs1048661](http://www.ncbi.nlm.nih.gov/snp/?term=rs1048661): I^2^ = 16%, p = 0.29; [rs3825942](http://www.ncbi.nlm.nih.gov/snp/?term=rs3825942): I^2^ = 0%, p = 0.48), Therefore, the data were combined using the fixed effects model. For [rs2165241](http://www.ncbi.nlm.nih.gov/snp/?term=rs2165241), the meta-analysis results showed that the risk of POAG in individuals carrying the C allele was 1.26 times compared to those carrying the T allele (OR = 1.26, 95% confident interval (CI): 1.09 \~1.46, p = 0.002) in the total population ([Figure 2](#f2){ref-type="fig"}). In the Caucasian population, we found that individuals carrying the C allele of [rs2165241](http://www.ncbi.nlm.nih.gov/snp/?term=rs2165241) have an increased risk for POAG compared to those subjects carrying the T allele (OR = 1.42, 95% CI: 1.19 \~1.69, p = 0.0001). However, we found no association in the Asian population (p = 0.64, [Figure 3](#f3){ref-type="fig"}).
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For [rs1048661](http://www.ncbi.nlm.nih.gov/snp/?term=rs1048661) and [rs3825942](http://www.ncbi.nlm.nih.gov/snp/?term=rs3825942), we found no associations between the genotype or allele and POAG in the total population ([Figure 4](#f4){ref-type="fig"} and [Figure 5](#f5){ref-type="fig"}). However, we found that the [rs1048661](http://www.ncbi.nlm.nih.gov/snp/?term=rs1048661) polymorphism was associated with POAG in the Asian population (OR = 1.17, 95% CI: 1.02 \~1.35, p = 0.03, [Figure 6](#f6){ref-type="fig"}), and [rs3825942](http://www.ncbi.nlm.nih.gov/snp/?term=rs3825942) was associated with POAG in the Caucasian population (OR = 2.69, 95% CI: 1.61 \~4.47, p\<0.001, [Figure 7](#f7){ref-type="fig"}).
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![Forest plot of the association of POAG with [rs3825942](http://www.ncbi.nlm.nih.gov/snp/?term=rs3825942) in the total population; the horizontal lines correspond to the study-specific OR and 95% CI, respectively. The area of the squares reflects the study-specific weight. The diamond represents the pooled results of the OR and 95%CI. In this analysis, a fixed-effects model was used.](mv-v21-165-f5){#f5}

![Forest plot of the association of POAG with [rs1048661](http://www.ncbi.nlm.nih.gov/snp/?term=rs1048661) in the Caucasian and Asian populations; the horizontal lines correspond to the study-specific OR and 95% CI, respectively. The area of the squares reflects the study-specific weight. The diamond represents the pooled results of the OR and 95%CI. In this analysis, a fixed-effects model was used.](mv-v21-165-f6){#f6}

![Forest plot of the association of POAG with [rs3825942](http://www.ncbi.nlm.nih.gov/snp/?term=rs3825942) in the Caucasian and Asian populations; the horizontal lines correspond to the study-specific OR and 95% CI, respectively. The area of the squares reflects the study-specific weight. The diamond represents the pooled results of the OR and 95%CI. In this analysis, a fixed-effects model was used.](mv-v21-165-f7){#f7}

Publication bias analysis
-------------------------

We analyzed the publication bias using Revman 5.2 software; the funnel plot shows the points as evenly distributed and symmetric, and most of the points are within the 95% CI. This indicates no publication bias, and the result of the study is credible ([Figure 8](#f8){ref-type="fig"}).
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Discussion
==========

In the present study, 13 literatures were included in a meta-analysis to investigate the relationship between the *LOXL1* gene polymorphisms and POAG. The results showed that the genetic polymorphisms of *LOXL1* were associated with a risk of POAG.

*LOXL1* is located on human chromosome 15q22, and it is a member of the lysyl oxidase family \[[@r31]\], members of which can encode a kind of copper-dependent amino oxidase. This enzyme acted on the cell, and it catalyzes the first step of the cross-linking reaction between collagen and elastin \[[@r32]\]. The gene-encoded protein is a secreted protein; after that, it is synthesized in the form of a precursor, and it is glycosylated in the Golgi complex and secreted out of the cells in the plasminogen state. Under the action of the proteolytic enzymes, *LOXL1* can convert to an active form and act on the elastic and collagen fibers in the extracellular matrix. *LOXL1* expression upregulation and abnormally high levels of enzyme activity can cause excessive collagen accumulation and result in the occurrence and development of related diseases, such as POAG. The [rs2165241](http://www.ncbi.nlm.nih.gov/snp/?term=rs2165241) of the *LOXL1* gene is located in the coding region of the gene. Thus, the polymorphism may be associated with the expressed products. The *LOXL1* protein encoded by the C allele is different from the protein encoded by the T allele in the primary and spatial structures \[[@r12]\], which will result in changes to the biologic function of the protein, and it will eventually result in different incidences of POAG in individuals carrying different alleles. The other two SNPs ([rs1048661](http://www.ncbi.nlm.nih.gov/snp/?term=rs1048661) and [rs3825942](http://www.ncbi.nlm.nih.gov/snp/?term=rs3825942)) are non-synonymous variants, which may affect protein function or expression. In the present study, we used meta-analysis methods to investigate the relationships between these three SNPs in the *LOXL1* gene and POAG, which has certain advantages. We found that in the Caucasian population, individuals carrying the C allele of [rs2165241](http://www.ncbi.nlm.nih.gov/snp/?term=rs2165241) have an increased 1.42-fold risk for POAG compared to those subjects carrying the T allele. In addition, we found that the [rs1048661](http://www.ncbi.nlm.nih.gov/snp/?term=rs1048661) polymorphism was associated with POAG in the Asian population and [rs3825942](http://www.ncbi.nlm.nih.gov/snp/?term=rs3825942) was associated with POAG in the Caucasian population. We found neither heterogeneity nor a publication bias among the studies. In addition, the sensitivity analysis showed that the results were stable and reliable. In conclusion, the present study indicated that *LOXL1* genetic polymorphisms are associated with susceptibility to POAG.
